FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2108804344> ?p ?o ?g. }

• W2108804344 endingPage "2847" @default.
• W2108804344 startingPage "2839" @default.
• W2108804344 abstract "Circulating lipoproteins and their protein constituents, apolipoproteins, are risk factors for chronic kidney disease (CKD). The associations between apolipoprotein A1, apolipoprotein B and their ratio with glomerular filtration rate estimated from the new CKD Epidemiology Collaboration (CKD-EPI) equation (eGFR) are not well studied in the general population. Associations between apolipoprotein A1, B and their ratio with the outcomes of eGFR, CKD (eGFR <60 mL/min/1.73m2) and albuminuria were examined in the Atherosclerosis Risk in Communities study (ARIC, n = 10 292, 1996–98) and the Third National Health and Nutrition Examination Survey (NHANES III, n = 7023, 1988–91). Cross-sectional multivariable-adjusted analyses were performed using linear and logistic regression. Prospective analyses related baseline apolipoprotein levels to subsequent CKD incidence over 10 years using the ARIC Carotid MRI follow-up cohort (n = 1659). Higher apolipoprotein A1 quartiles were associated with a lower prevalence of CKD [Q4 versus Q1: odds ratio (OR) 0.73, P-trend = 0.02 in ARIC; Q4 versus Q1: OR 0.53, P-trend <0.01 in NHANES III] as well as with higher eGFR (P-trend <0.01 in ARIC and NHANES III). No consistent significant associations were found for apolipoprotein B in either study. The apolipoprotein B/A1 ratio was significantly associated with eGFR across quartiles in both studies (P-trend <0.01) and with CKD in ARIC (Q4 versus Q1: OR 1.23, P-trend = 0.01). Prospectively, there were trends for the association of apolipoproteins with incident CKD [Q4 versus Q1: incidence rate ratio (IRR) = 0.68 for apolipoprotein A1, P-trend = 0.1; Q4 versus Q1: IRR = 1.35 for apolipoprotein B, P-trend = 0.2]. Associations were not systematically stronger when comparing traditional lipids (total cholesterol, low-density lipoprotein or high-density lipoprotein) to apolipoproteins. Higher serum apolipoprotein A1 was associated with lower prevalence of CKD and higher eGFR estimated by the CKD-EPI equation in two large multiethnic population-based samples. While apolipoprotein B showed no consistent associations, a higher apolipoprotein B/A1 ratio was significantly associated with lower eGFR in both studies. The direction and magnitude of the longitudinal associations between apolipoproteins and CKD incidence were overall similar to those observed cross-sectionally. No consistent differences became apparent between traditional lipids and apolipoproteins." @default.
• W2108804344 created "2016-06-24" @default.
• W2108804344 creator A5002731748 @default.
• W2108804344 creator A5047227825 @default.
• W2108804344 creator A5048938940 @default.
• W2108804344 creator A5052604218 @default.
• W2108804344 creator A5071554578 @default.
• W2108804344 creator A5086328297 @default.
• W2108804344 date "2012-01-28" @default.
• W2108804344 modified "2023-09-27" @default.
• W2108804344 title "Association of apolipoprotein A1 and B with kidney function and chronic kidney disease in two multiethnic population samples" @default.
• W2108804344 cites W16445148 @default.
• W2108804344 cites W1982729232 @default.
• W2108804344 cites W1988933958 @default.
• W2108804344 cites W1990092121 @default.
• W2108804344 cites W1991431342 @default.
• W2108804344 cites W1996711109 @default.
• W2108804344 cites W1997820115 @default.
• W2108804344 cites W2005263621 @default.
• W2108804344 cites W2010052835 @default.
• W2108804344 cites W2011627164 @default.
• W2108804344 cites W2011910330 @default.
• W2108804344 cites W2012766272 @default.
• W2108804344 cites W2016837245 @default.
• W2108804344 cites W2016918979 @default.
• W2108804344 cites W2026067246 @default.
• W2108804344 cites W2040433877 @default.
• W2108804344 cites W2045054080 @default.
• W2108804344 cites W2045516356 @default.
• W2108804344 cites W2049102934 @default.
• W2108804344 cites W2054395645 @default.
• W2108804344 cites W2058562880 @default.
• W2108804344 cites W2059371152 @default.
• W2108804344 cites W2082184283 @default.
• W2108804344 cites W2082447097 @default.
• W2108804344 cites W2089103283 @default.
• W2108804344 cites W2102227401 @default.
• W2108804344 cites W2104765250 @default.
• W2108804344 cites W2105103856 @default.
• W2108804344 cites W2109938153 @default.
• W2108804344 cites W2113923344 @default.
• W2108804344 cites W2118780561 @default.
• W2108804344 cites W2119087702 @default.
• W2108804344 cites W2120084982 @default.
• W2108804344 cites W2122073745 @default.
• W2108804344 cites W2124641083 @default.
• W2108804344 cites W2125196521 @default.
• W2108804344 cites W2127427274 @default.
• W2108804344 cites W2128730397 @default.
• W2108804344 cites W2141269765 @default.
• W2108804344 cites W2155019824 @default.
• W2108804344 cites W2155965977 @default.
• W2108804344 cites W2159790848 @default.
• W2108804344 cites W2159995160 @default.
• W2108804344 cites W2160452475 @default.
• W2108804344 cites W2164576143 @default.
• W2108804344 cites W2269468145 @default.
• W2108804344 cites W4214663222 @default.
• W2108804344 cites W4242416368 @default.
• W2108804344 doi "https://doi.org/10.1093/ndt/gfr795" @default.
• W2108804344 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/3471548" @default.
• W2108804344 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/22287661" @default.
• W2108804344 hasPublicationYear "2012" @default.
• W2108804344 type Work @default.
• W2108804344 sameAs 2108804344 @default.
• W2108804344 citedByCount "36" @default.
• W2108804344 countsByYear W21088043442012 @default.
• W2108804344 countsByYear W21088043442013 @default.
• W2108804344 countsByYear W21088043442014 @default.
• W2108804344 countsByYear W21088043442015 @default.
• W2108804344 countsByYear W21088043442017 @default.
• W2108804344 countsByYear W21088043442018 @default.
• W2108804344 countsByYear W21088043442019 @default.
• W2108804344 countsByYear W21088043442020 @default.
• W2108804344 countsByYear W21088043442021 @default.
• W2108804344 countsByYear W21088043442022 @default.
• W2108804344 countsByYear W21088043442023 @default.
• W2108804344 crossrefType "journal-article" @default.
• W2108804344 hasAuthorship W2108804344A5002731748 @default.
• W2108804344 hasAuthorship W2108804344A5047227825 @default.
• W2108804344 hasAuthorship W2108804344A5048938940 @default.
• W2108804344 hasAuthorship W2108804344A5052604218 @default.
• W2108804344 hasAuthorship W2108804344A5071554578 @default.
• W2108804344 hasAuthorship W2108804344A5086328297 @default.
• W2108804344 hasBestOaLocation W21088043441 @default.
• W2108804344 hasConcept C120665830 @default.
• W2108804344 hasConcept C121332964 @default.
• W2108804344 hasConcept C126322002 @default.
• W2108804344 hasConcept C134018914 @default.
• W2108804344 hasConcept C156957248 @default.
• W2108804344 hasConcept C159641895 @default.
• W2108804344 hasConcept C188816634 @default.
• W2108804344 hasConcept C2776174234 @default.
• W2108804344 hasConcept C2778163477 @default.
• W2108804344 hasConcept C2778653478 @default.
• W2108804344 hasConcept C2779874844 @default.
• W2108804344 hasConcept C2908647359 @default.
• W2108804344 hasConcept C44249647 @default.

• next